Tag Archives: RG7204

New Personalized Medicine Increases Survival in Melanoma Patients

Metastatic melanoma is the deadliest and most aggressive from of skin cancer.  A person with metastatic melanoma typically has a short life expectancy that is measured in months.   The mainstay treatments for metastatic melanoma are dacarbazine (DTIC), interleukin-2 (IL-2) and … Continue reading

Posted in Cancer, Melanoma | Tagged , , , , , , , , , , , , , , | Comments Off on New Personalized Medicine Increases Survival in Melanoma Patients